Condition
Constriction, Pathologic
Total Trials
6
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Terminated1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05817747Not ApplicableRecruitingPrimary
Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis
NCT06681584Active Not Recruiting
Comparison of the Diagnostic Performance and Costs of FFRB Vs. Standard Care in Suspected Coronary Artery Disease.
NCT05536310Not Yet Recruiting
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
NCT00614315Not ApplicableCompletedPrimary
FLAIR™ Delivery System Study
NCT01343667Not ApplicableCompleted
GORE Flow Reversal System and GORE Embolic Filter Extension Study
NCT00004728Phase 3Terminated
Aspirin Or Warfarin To Prevent Stroke
Showing all 6 trials